E. Ohman J:Or Asset Management Ab Dexcom Inc Transaction History

E. Ohman J:Or Asset Management Ab

$3.76 Trillion
Q1 2025

A detailed history of E. Ohman J:Or Asset Management Ab transactions in Dexcom Inc stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 15,492 shares of DXCM stock, worth $1.04 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

15,492

Previous 17,600 11.98%

Holding current value

$1.04 Million

Previous $1.37 Billion 22.71%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 11, 2025	SELL	$67.74 - $90.75 $142,795 - $191,301	-2,108 Reduced 11.98%	15,492 $1.06 Billion
Q4 2024 Jan 27, 2025	BUY	$65.68 - $81.01 $124,792 - $153,919	1,900 Added 12.1%	17,600 $1.37 Billion
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $125,642 - $154,110	1,100 Added 7.53%	15,700 $2.18 Billion
Q4 2023 Feb 15, 2024	SELL	$75.49 - $124.16 $256,665 - $422,144	-3,400 Reduced 18.89%	14,600 $1.81 Billion
Q3 2023 Feb 06, 2024	BUY	$86.06 - $137.93 $1.55 Million - $2.48 Million	18,000 New	18,000 $1.68 Billion
Q2 2023 Apr 05, 2024	BUY	$112.47 - $130.98 $134,964 - $157,176	1,200 Added 7.14%	18,000 $2.31 Billion
Q2 2022 Apr 05, 2024	BUY	$67.99 - $132.89 $856,673 - $1.67 Million	12,600 Added 300.0%	16,800 $1.25 Billion
Q1 2022 Apr 05, 2024	SELL	$94.08 - $130.2 $6.95 Million - $9.62 Million	-73,871 Reduced 94.62%	4,200 $2.15 Billion
Q4 2021 Apr 05, 2024	SELL	$129.87 - $162.82 $2.21 Million - $2.77 Million	-17,040 Reduced 17.92%	78,071 $41.9 Billion
Q3 2021 Apr 05, 2024	SELL	$106.71 - $143.18 $452,450 - $607,083	-4,240 Reduced 4.27%	95,111 $52 Billion
Q2 2021 Apr 05, 2024	BUY	$80.99 - $107.93 $5.14 Million - $6.85 Million	63,500 Added 177.12%	99,351 $42.4 Billion
Q1 2021 Apr 05, 2024	BUY	$84.79 - $104.74 $873,337 - $1.08 Million	10,300 Added 40.31%	35,851 $12.9 Billion
Q4 2020 Apr 05, 2024	BUY	$78.0 - $104.5 $756,600 - $1.01 Million	9,700 Added 61.19%	25,551 $9.45 Billion
Q3 2020 Apr 05, 2024	BUY	$95.51 - $112.95 $238,775 - $282,375	2,500 Added 18.73%	15,851 $6.53 Billion
Q2 2020 Apr 05, 2024	SELL	$62.68 - $105.34 $2.33 Million - $3.92 Million	-37,220 Reduced 73.6%	13,351 $5.41 Billion
Q1 2020 Apr 05, 2024	BUY	$47.79 - $75.63 $2.08 Million - $3.3 Million	43,620 Added 627.54%	50,571 $13.6 Billion
Q4 2019 Apr 05, 2024	SELL	$36.62 - $57.29 $29,295 - $45,832	-800 Reduced 10.32%	6,951 $1.52 Billion
Q3 2019 Apr 05, 2024	SELL	$35.53 - $43.8 $37,235 - $45,902	-1,048 Reduced 11.91%	7,751 $1.16 Billion
Q2 2019 Apr 05, 2024	BUY	$27.84 - $38.92 $41,342 - $57,796	1,485 Added 20.3%	8,799 $1.32 Billion
Q1 2019 Apr 05, 2024	SELL	$28.07 - $38.18 $784,135 - $1.07 Million	-27,935 Reduced 79.25%	7,314 $871 Million
Q4 2018 Apr 05, 2024	BUY	$26.99 - $37.37 $951,370 - $1.32 Million	35,249 New	35,249 $4.22 Billion
Q4 2017 Apr 05, 2024	SELL	$11.12 - $15.38 $23,352 - $32,298	-2,100 Closed	0 $0
Q3 2017 Apr 05, 2024	BUY	$11.36 - $18.98 $1,136 - $1,898	100 Added 5.0%	2,100 $103 Million
Q4 2016 Apr 05, 2024	SELL	N/A	-12,600	2,000 $119 Million

Others Institutions Holding DXCM

# of Institutions

1,081

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.

Account

E. Ohman J:Or Asset Management Ab Dexcom Inc Transaction History